FDA Alert
FDA Alert
09/10/2025
Kate Young
The FDA recently announced the approval of rilzabrutinib tablets for adults with persistent or chronic immune thrombocytopenia who did not respond to immunoglobulins, anti-D therapy, or corticosteroids. ...
09/10/2025
Autoimmune diseases
Autoimmune diseases
12/12/2017
The US Food and Drug Administration has recently approved the first treatment option for patients with eosinophilic granulomatosis with polyangiitis.
12/12/2017